Pioneering Medicines: Senior Director, Head of Toxicology

Position Summary 

The Senior Director, Head of Toxicology will lead and build the toxicology function within Pioneering Medicines, defining and executing nonclinical safety strategies across a diverse and rapidly evolving portfolio. This role provides scientific and strategic leadership across both investigative and regulatory toxicology, supporting a broad range of therapeutic modalities. 

Working in a dynamic venture creation environment, you will collaborate closely with multidisciplinary teams to optimize candidate selection, guide preclinical development, and ensure regulatory readiness. This is a high-impact role requiring strong analytical thinking, scientific rigor, and clear communication, influencing programs from discovery through early clinical development. 

 

Key Responsibilities 

Functional Leadership & Capability Building 

• Lead, build, and scale the toxicology function, including internal team development and external partnerships  

• Define fit-for-purpose operating models spanning investigative and regulatory toxicology  

• Serve as the primary internal expert for nonclinical safety, ensuring quality, consistency, and scalability across the portfolio  

Portfolio & Program Strategy 

• Define and drive toxicology strategies across multiple programs and modalities   

• Translate findings into clear risk assessments, mitigation strategies, and IND/CTA-enabling plans  

• Enable transparent, data-driven decision-making by articulating risks, assumptions, and trade-offs to program teams  

• Oversee the design, execution, and interpretation of non-GLP and GLP toxicology studies  

• Partner cross-functionally (DMPK, pharmacology, CMC, clinical) to integrate safety into development strategy  

• Support diligence and evaluation of new programs within Flagship’s ecosystem  

External Partnerships & Regulatory 

• Build and manage a high-performing CRO and consultant network, ensuring quality, timelines, and cost efficiency  

• Leverage and contribute to the Flagship ecosystem, fostering knowledge sharing and collaboration across platform companies  

• Lead nonclinical regulatory strategy and documentation (INDs, IBs, briefing materials)  

• Ensure regulatory readiness through clear and scientifically robust safety narratives  

• Represent toxicology in regulatory interactions as appropriate  

 

Qualifications 

• PhD, DVM, or equivalent in Toxicology, Pathology, Pharmacology, or related field  

• ~10-15+ years of experience in nonclinical safety in biotech/pharma  

• Proven track record advancing programs through IND and into clinical development  

• Experience across multiple modalities preferred  

• Strong experience managing CROs and external collaborations  

• Experience leading or building a toxicology function or team, including management of internal scientists and/or external partners, is a plus  

Leadership Profile 

• Enterprise mindset; able to operate across a portfolio in a fast-paced, collaborative environment  

• Analytical and goal-oriented, with the ability to operate with urgency while maintaining high standards of scientific rigor and ethics  

• Strong communicator who can translate complex toxicology into clear, audience-appropriate risk assessments, from early-stage teams to large pharma partners  

 

About Flagship 

Flagship Pioneering is a scientific innovation engine that invents and builds companies that change the world. We bring together the greatest scientific minds with entrepreneurial company builders and assemble the capital to allow them to take courageous leaps in human health, sustainability, and beyond. 
 
What sets Flagship apart is our ability to advance biotechnology by uniting life science innovation, company creation, and capital investment under one roof in a way that is largely without precedent. Our team of scientists, entrepreneurial leaders, and professional capital managers are each aligned around an institutionalized process that enables us to innovate and create breakthroughs for the benefit of people and planet.  Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture. 

Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been named four times to Fast Company’s annual list of the World’s Most Innovative Companies. 

At Flagship, we recognize there is no perfect candidate. If you have some of the experience listed above but not all, please apply anyway. Experience comes in many forms, skills are transferable, and passion goes a long way. We are dedicated to building diverse and inclusive teams and look forward to learning more about your unique background. 

Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.

The salary range for this role is $228,000 - $280,000. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. Pioneering Medicines currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits. Compensation and benefits information is based on Pioneering Medicines's good faith estimate as of the date of publication and may be modified in the future.